我院2005—2007年抗菌药物利用分析  

Use of antibacterials in our hospital between 2005 and 2007

作　　者：王治海[1] 李梅 范惠霞 齐瑞芬[1] 

机构地区：[1]山西省肿瘤医院药剂科,太原030013 [2]山西省医疗机构管理研究所

出　　处：《中国药物与临床》2008年第6期462-464,共3页Chinese Remedies & Clinics

基　　金：山西省软科学研究项目(2007041030-03)

摘　　要：目的评价我院抗菌药物的应用现状及变化趋势。方法对我院2005—2007年抗菌药物的销售情况进行回顾性分析。结果复方制剂、头孢菌素和喹诺酮类占80%以上。2005—2007年抗菌药物的各项指标呈下降趋势,品规数由125种下降91种;人均抗菌药物的费用从1346.22元下降到1080.50元;抗菌药物占西药的销售比例从21.03%下降到18.54%。抗菌药物的销售量与患者增长的比例相比较出现下降趋势。结论我院抗菌药物的使用渐趋合理。Objective To evaluate the status quo and evolving change of antibacterial use in our hospital. Methods A retrospective analysis was performed on the sales of antibacterials in Shanxi Provincial Cancer Hospital from 2005 to 2007, Results Antibiotic composites, e, ephalosporins and quinolones accounted for 80% of the global sales. From 2005 to 2007, descending tendencies in antibacterial use were reflected in total numbers of products （from 125 to 91）, annualized costs for antibacterial therapy （from 1346.22 RMB to 1080.50 RMB） and percentage sales of antibacterial in all western medicines （from 21.03% to 18.54%）. Furthermore, the sales of antibacterials contrasted greatly with the increasing number of patients during the same period. Conclusion A trend towards rational use of antibacteriats was shown in our hospital, which may be attributed to regulatory factors.

关 键 词：抗菌药物 变化趋势 头孢菌素 西药 

分 类 号：R96[医药卫生—药理学]